IGFBP2 and obesity due to melanocortin 4 receptor deficiency: With respect to breast cancer and perhaps other obesity-related cancers such as colorectal cancer [37], the proliferative potential of IGFBP-2 may be countered by its role in obesity and adipocyte biology [38].